[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Veterinary Antiparasitic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

November 2023 | 106 pages | ID: G4D766567ECBEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Veterinary Antiparasitic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Parasitic infections are very common in the livestock industry and have serious consequences for animal health and performance. Therefore, the use of antiparasitic drugs is an important means of preventing and treating parasitic infections.

The Global Info Research report includes an overview of the development of the Veterinary Antiparasitic Drugs industry chain, the market status of Farm (Antihelmintics, Antiprotozoal Drugs), Zoo (Antihelmintics, Antiprotozoal Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Antiparasitic Drugs.

Regionally, the report analyzes the Veterinary Antiparasitic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Antiparasitic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Veterinary Antiparasitic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Antiparasitic Drugs industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Antihelmintics, Antiprotozoal Drugs).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Antiparasitic Drugs market.

Regional Analysis: The report involves examining the Veterinary Antiparasitic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Antiparasitic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Veterinary Antiparasitic Drugs:

Company Analysis: Report covers individual Veterinary Antiparasitic Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Antiparasitic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Farm, Zoo).

Technology Analysis: Report covers specific technologies relevant to Veterinary Antiparasitic Drugs. It assesses the current state, advancements, and potential future developments in Veterinary Antiparasitic Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Antiparasitic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Veterinary Antiparasitic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Antihelmintics
  • Antiprotozoal Drugs
Market segment by Application
  • Farm
  • Zoo
  • Others
Major players covered
  • Weefsel Pharma
  • Meiji Group
  • Biowet
  • HPRA
  • Medinfar Sorologico
  • Boehringer Ingelheim Animal Health
  • VET -AGRO
  • Mobedco
  • Merck KGaA
  • VIC
  • Vetsintez
  • Cadila Pharmaceuticals
  • Watson International Limited
  • VivaldisGlenmark Pharmaceuticals Limited
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Veterinary Antiparasitic Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Veterinary Antiparasitic Drugs, with price, sales, revenue and global market share of Veterinary Antiparasitic Drugs from 2018 to 2023.

Chapter 3, the Veterinary Antiparasitic Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Veterinary Antiparasitic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Antiparasitic Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Antiparasitic Drugs.

Chapter 14 and 15, to describe Veterinary Antiparasitic Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Veterinary Antiparasitic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Veterinary Antiparasitic Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Antihelmintics
  1.3.3 Antiprotozoal Drugs
1.4 Market Analysis by Application
  1.4.1 Overview: Global Veterinary Antiparasitic Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Farm
  1.4.3 Zoo
  1.4.4 Others
1.5 Global Veterinary Antiparasitic Drugs Market Size & Forecast
  1.5.1 Global Veterinary Antiparasitic Drugs Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Veterinary Antiparasitic Drugs Sales Quantity (2018-2029)
  1.5.3 Global Veterinary Antiparasitic Drugs Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Weefsel Pharma
  2.1.1 Weefsel Pharma Details
  2.1.2 Weefsel Pharma Major Business
  2.1.3 Weefsel Pharma Veterinary Antiparasitic Drugs Product and Services
  2.1.4 Weefsel Pharma Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Weefsel Pharma Recent Developments/Updates
2.2 Meiji Group
  2.2.1 Meiji Group Details
  2.2.2 Meiji Group Major Business
  2.2.3 Meiji Group Veterinary Antiparasitic Drugs Product and Services
  2.2.4 Meiji Group Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Meiji Group Recent Developments/Updates
2.3 Biowet
  2.3.1 Biowet Details
  2.3.2 Biowet Major Business
  2.3.3 Biowet Veterinary Antiparasitic Drugs Product and Services
  2.3.4 Biowet Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Biowet Recent Developments/Updates
2.4 HPRA
  2.4.1 HPRA Details
  2.4.2 HPRA Major Business
  2.4.3 HPRA Veterinary Antiparasitic Drugs Product and Services
  2.4.4 HPRA Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 HPRA Recent Developments/Updates
2.5 Medinfar Sorologico
  2.5.1 Medinfar Sorologico Details
  2.5.2 Medinfar Sorologico Major Business
  2.5.3 Medinfar Sorologico Veterinary Antiparasitic Drugs Product and Services
  2.5.4 Medinfar Sorologico Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Medinfar Sorologico Recent Developments/Updates
2.6 Boehringer Ingelheim Animal Health
  2.6.1 Boehringer Ingelheim Animal Health Details
  2.6.2 Boehringer Ingelheim Animal Health Major Business
  2.6.3 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Product and Services
  2.6.4 Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
2.7 VET -AGRO
  2.7.1 VET -AGRO Details
  2.7.2 VET -AGRO Major Business
  2.7.3 VET -AGRO Veterinary Antiparasitic Drugs Product and Services
  2.7.4 VET -AGRO Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 VET -AGRO Recent Developments/Updates
2.8 Mobedco
  2.8.1 Mobedco Details
  2.8.2 Mobedco Major Business
  2.8.3 Mobedco Veterinary Antiparasitic Drugs Product and Services
  2.8.4 Mobedco Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Mobedco Recent Developments/Updates
2.9 Merck KGaA
  2.9.1 Merck KGaA Details
  2.9.2 Merck KGaA Major Business
  2.9.3 Merck KGaA Veterinary Antiparasitic Drugs Product and Services
  2.9.4 Merck KGaA Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Merck KGaA Recent Developments/Updates
2.10 VIC
  2.10.1 VIC Details
  2.10.2 VIC Major Business
  2.10.3 VIC Veterinary Antiparasitic Drugs Product and Services
  2.10.4 VIC Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 VIC Recent Developments/Updates
2.11 Vetsintez
  2.11.1 Vetsintez Details
  2.11.2 Vetsintez Major Business
  2.11.3 Vetsintez Veterinary Antiparasitic Drugs Product and Services
  2.11.4 Vetsintez Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Vetsintez Recent Developments/Updates
2.12 Cadila Pharmaceuticals
  2.12.1 Cadila Pharmaceuticals Details
  2.12.2 Cadila Pharmaceuticals Major Business
  2.12.3 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Product and Services
  2.12.4 Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Cadila Pharmaceuticals Recent Developments/Updates
2.13 Watson International Limited
  2.13.1 Watson International Limited Details
  2.13.2 Watson International Limited Major Business
  2.13.3 Watson International Limited Veterinary Antiparasitic Drugs Product and Services
  2.13.4 Watson International Limited Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Watson International Limited Recent Developments/Updates
2.14 VivaldisGlenmark Pharmaceuticals Limited
  2.14.1 VivaldisGlenmark Pharmaceuticals Limited Details
  2.14.2 VivaldisGlenmark Pharmaceuticals Limited Major Business
  2.14.3 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Product and Services
  2.14.4 VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 VivaldisGlenmark Pharmaceuticals Limited Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: VETERINARY ANTIPARASITIC DRUGS BY MANUFACTURER

3.1 Global Veterinary Antiparasitic Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Veterinary Antiparasitic Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Veterinary Antiparasitic Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Veterinary Antiparasitic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Veterinary Antiparasitic Drugs Manufacturer Market Share in 2022
  3.4.2 Top 6 Veterinary Antiparasitic Drugs Manufacturer Market Share in 2022
3.5 Veterinary Antiparasitic Drugs Market: Overall Company Footprint Analysis
  3.5.1 Veterinary Antiparasitic Drugs Market: Region Footprint
  3.5.2 Veterinary Antiparasitic Drugs Market: Company Product Type Footprint
  3.5.3 Veterinary Antiparasitic Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Veterinary Antiparasitic Drugs Market Size by Region
  4.1.1 Global Veterinary Antiparasitic Drugs Sales Quantity by Region (2018-2029)
  4.1.2 Global Veterinary Antiparasitic Drugs Consumption Value by Region (2018-2029)
  4.1.3 Global Veterinary Antiparasitic Drugs Average Price by Region (2018-2029)
4.2 North America Veterinary Antiparasitic Drugs Consumption Value (2018-2029)
4.3 Europe Veterinary Antiparasitic Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value (2018-2029)
4.5 South America Veterinary Antiparasitic Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Veterinary Antiparasitic Drugs Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
5.2 Global Veterinary Antiparasitic Drugs Consumption Value by Type (2018-2029)
5.3 Global Veterinary Antiparasitic Drugs Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
6.2 Global Veterinary Antiparasitic Drugs Consumption Value by Application (2018-2029)
6.3 Global Veterinary Antiparasitic Drugs Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
7.2 North America Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
7.3 North America Veterinary Antiparasitic Drugs Market Size by Country
  7.3.1 North America Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2029)
  7.3.2 North America Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Veterinary Antiparasitic Drugs Market Size by Country
  8.3.1 Europe Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2029)
  8.3.2 Europe Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Veterinary Antiparasitic Drugs Market Size by Region
  9.3.1 Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
10.2 South America Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
10.3 South America Veterinary Antiparasitic Drugs Market Size by Country
  10.3.1 South America Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2029)
  10.3.2 South America Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Veterinary Antiparasitic Drugs Market Size by Country
  11.3.1 Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Veterinary Antiparasitic Drugs Market Drivers
12.2 Veterinary Antiparasitic Drugs Market Restraints
12.3 Veterinary Antiparasitic Drugs Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Veterinary Antiparasitic Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Antiparasitic Drugs
13.3 Veterinary Antiparasitic Drugs Production Process
13.4 Veterinary Antiparasitic Drugs Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Veterinary Antiparasitic Drugs Typical Distributors
14.3 Veterinary Antiparasitic Drugs Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION


16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Veterinary Antiparasitic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Veterinary Antiparasitic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Weefsel Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Weefsel Pharma Major Business
Table 5. Weefsel Pharma Veterinary Antiparasitic Drugs Product and Services
Table 6. Weefsel Pharma Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Weefsel Pharma Recent Developments/Updates
Table 8. Meiji Group Basic Information, Manufacturing Base and Competitors
Table 9. Meiji Group Major Business
Table 10. Meiji Group Veterinary Antiparasitic Drugs Product and Services
Table 11. Meiji Group Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Meiji Group Recent Developments/Updates
Table 13. Biowet Basic Information, Manufacturing Base and Competitors
Table 14. Biowet Major Business
Table 15. Biowet Veterinary Antiparasitic Drugs Product and Services
Table 16. Biowet Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Biowet Recent Developments/Updates
Table 18. HPRA Basic Information, Manufacturing Base and Competitors
Table 19. HPRA Major Business
Table 20. HPRA Veterinary Antiparasitic Drugs Product and Services
Table 21. HPRA Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. HPRA Recent Developments/Updates
Table 23. Medinfar Sorologico Basic Information, Manufacturing Base and Competitors
Table 24. Medinfar Sorologico Major Business
Table 25. Medinfar Sorologico Veterinary Antiparasitic Drugs Product and Services
Table 26. Medinfar Sorologico Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Medinfar Sorologico Recent Developments/Updates
Table 28. Boehringer Ingelheim Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim Animal Health Major Business
Table 30. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Product and Services
Table 31. Boehringer Ingelheim Animal Health Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 33. VET -AGRO Basic Information, Manufacturing Base and Competitors
Table 34. VET -AGRO Major Business
Table 35. VET -AGRO Veterinary Antiparasitic Drugs Product and Services
Table 36. VET -AGRO Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. VET -AGRO Recent Developments/Updates
Table 38. Mobedco Basic Information, Manufacturing Base and Competitors
Table 39. Mobedco Major Business
Table 40. Mobedco Veterinary Antiparasitic Drugs Product and Services
Table 41. Mobedco Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mobedco Recent Developments/Updates
Table 43. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 44. Merck KGaA Major Business
Table 45. Merck KGaA Veterinary Antiparasitic Drugs Product and Services
Table 46. Merck KGaA Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Merck KGaA Recent Developments/Updates
Table 48. VIC Basic Information, Manufacturing Base and Competitors
Table 49. VIC Major Business
Table 50. VIC Veterinary Antiparasitic Drugs Product and Services
Table 51. VIC Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. VIC Recent Developments/Updates
Table 53. Vetsintez Basic Information, Manufacturing Base and Competitors
Table 54. Vetsintez Major Business
Table 55. Vetsintez Veterinary Antiparasitic Drugs Product and Services
Table 56. Vetsintez Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Vetsintez Recent Developments/Updates
Table 58. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Cadila Pharmaceuticals Major Business
Table 60. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Product and Services
Table 61. Cadila Pharmaceuticals Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Cadila Pharmaceuticals Recent Developments/Updates
Table 63. Watson International Limited Basic Information, Manufacturing Base and Competitors
Table 64. Watson International Limited Major Business
Table 65. Watson International Limited Veterinary Antiparasitic Drugs Product and Services
Table 66. Watson International Limited Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Watson International Limited Recent Developments/Updates
Table 68. VivaldisGlenmark Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 69. VivaldisGlenmark Pharmaceuticals Limited Major Business
Table 70. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Product and Services
Table 71. VivaldisGlenmark Pharmaceuticals Limited Veterinary Antiparasitic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. VivaldisGlenmark Pharmaceuticals Limited Recent Developments/Updates
Table 73. Global Veterinary Antiparasitic Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Veterinary Antiparasitic Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Veterinary Antiparasitic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Veterinary Antiparasitic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Veterinary Antiparasitic Drugs Production Site of Key Manufacturer
Table 78. Veterinary Antiparasitic Drugs Market: Company Product Type Footprint
Table 79. Veterinary Antiparasitic Drugs Market: Company Product Application Footprint
Table 80. Veterinary Antiparasitic Drugs New Market Entrants and Barriers to Market Entry
Table 81. Veterinary Antiparasitic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Veterinary Antiparasitic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Veterinary Antiparasitic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Veterinary Antiparasitic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Veterinary Antiparasitic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Veterinary Antiparasitic Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Veterinary Antiparasitic Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Veterinary Antiparasitic Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Veterinary Antiparasitic Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Veterinary Antiparasitic Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Veterinary Antiparasitic Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Veterinary Antiparasitic Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Veterinary Antiparasitic Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Veterinary Antiparasitic Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Veterinary Antiparasitic Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Veterinary Antiparasitic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Veterinary Antiparasitic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Veterinary Antiparasitic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Veterinary Antiparasitic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Veterinary Antiparasitic Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Veterinary Antiparasitic Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Veterinary Antiparasitic Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Veterinary Antiparasitic Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Veterinary Antiparasitic Drugs Raw Material
Table 141. Key Manufacturers of Veterinary Antiparasitic Drugs Raw Materials
Table 142. Veterinary Antiparasitic Drugs Typical Distributors
Table 143. Veterinary Antiparasitic Drugs Typical Customers

LIST OF FIGURE
s
Figure 1. Veterinary Antiparasitic Drugs Picture
Figure 2. Global Veterinary Antiparasitic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Type in 2022
Figure 4. Antihelmintics Examples
Figure 5. Antiprotozoal Drugs Examples
Figure 6. Global Veterinary Antiparasitic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Application in 2022
Figure 8. Farm Examples
Figure 9. Zoo Examples
Figure 10. Others Examples
Figure 11. Global Veterinary Antiparasitic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Veterinary Antiparasitic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Veterinary Antiparasitic Drugs Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Veterinary Antiparasitic Drugs Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Veterinary Antiparasitic Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Veterinary Antiparasitic Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Veterinary Antiparasitic Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Veterinary Antiparasitic Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Veterinary Antiparasitic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Veterinary Antiparasitic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Veterinary Antiparasitic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Veterinary Antiparasitic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Veterinary Antiparasitic Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Veterinary Antiparasitic Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Veterinary Antiparasitic Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Veterinary Antiparasitic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Veterinary Antiparasitic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Veterinary Antiparasitic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Veterinary Antiparasitic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Veterinary Antiparasitic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 53. China Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Veterinary Antiparasitic Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Veterinary Antiparasitic Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Veterinary Antiparasitic Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Veterinary Antiparasitic Drugs Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Veterinary Antiparasitic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Veterinary Antiparasitic Drugs Market Drivers
Figure 74. Veterinary Antiparasitic Drugs Market Restraints
Figure 75. Veterinary Antiparasitic Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Veterinary Antiparasitic Drugs in 2022
Figure 78. Manufacturing Process Analysis of Veterinary Antiparasitic Drugs
Figure 79. Veterinary Antiparasitic Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications